human CD40 agonist ligand (ISA Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehuman CD40 agonist ligand (ISA Pharmaceuticals)
Drug Alias Nameagonistic anti-CD40 mAb (ISA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIsa Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsa Pharmaceuticals Bv
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A